Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis

R Pal, M Banerjee, S K Bhadada, A J Shetty, B Singh, A Vyas, R Pal, M Banerjee, S K Bhadada, A J Shetty, B Singh, A Vyas

Abstract

Purpose: To provide a precise summary and collate the hitherto available clinical evidence on the effect of vitamin D supplementation on clinical outcomes in COVID-19 patients.

Methods: PubMed/MEDLINE, Scopus, and Web of Science databases were systematically searched using appropriate keywords till June 8, 2021, to identify observational studies and randomized controlled trials (RCTs) reporting adverse clinical outcomes (ICU admission and/or mortality) in COVID-19 patients receiving vitamin D supplementation vs. those not receiving the same. Both prior use and use of vitamin D after COVID-19 diagnosis were considered. Unadjusted/adjusted pooled odds ratio (OR) with 95% confidence intervals (CI) were calculated (PROSPERO registration number CRD42021248488).

Results: We identified 13 studies (10 observational, 3 RCTs) pooling data retrieved from 2933 COVID-19 patients. Pooled analysis of unadjusted data showed that vitamin D use in COVID-19 was significantly associated with reduced ICU admission/mortality (OR 0.41, 95% CI: 0.20, 0.81, p = 0.01, I2 = 66%, random-effects model). Similarly, on pooling adjusted risk estimates, vitamin D was also found to reduce the risk of adverse outcomes (pooled OR 0.27, 95% CI: 0.08, 0.91, p = 0.03, I2 = 80%, random-effects model). Subgroup analysis showed that vitamin D supplementation was associated with improved clinical outcomes only in patients receiving the drug post-COVID-19 diagnosis and not in those who had received vitamin D before diagnosis.

Conclusions: Vitamin D supplementation might be associated with improved clinical outcomes, especially when administered after the diagnosis of COVID-19. However, issues regarding the appropriate dose, duration, and mode of administration of vitamin D remain unanswered and need further research.

Keywords: COVID-19; ICU admission; Mortality; Vitamin D.

Conflict of interest statement

None to declare.

© 2021. Italian Society of Endocrinology (SIE).

Figures

Fig. 1
Fig. 1
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart showing the study selection process
Fig. 2
Fig. 2
Forest plot showing the effect (unadjusted) of vitamin D supplementation on clinical outcomes (intensive care unit admission and/or mortality) in patients with COVID-19 as compared to non-use of vitamin D
Fig. 3
Fig. 3
Forest plot with subgroup analysis (based on the use of vitamin D pre- or post-COVID-19 diagnosis) showing the effect (unadjusted) of vitamin D supplementation on clinical outcomes (intensive care unit admission and/or mortality) in patients with COVID-19 as compared to non-use of vitamin D
Fig. 4
Fig. 4
Forest plots showing the effect (adjusted) of vitamin D supplementation on clinical outcomes (intensive care unit admission and/or mortality) in patients with COVID-19 as compared to non-use of vitamin D expressed either as pooled odds ratio (A) or pooled hazard ratio (B)

References

    1. Meltzer DO, Best TJ, Zhang H, et al. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open. 2020;3:e2019722. doi: 10.1001/jamanetworkopen.2020.19722.
    1. Pal R, Ram S, Zohmangaihi D, et al. High prevalence of hypocalcemia in non-severe COVID-19 patients: a retrospective case-control study. Front Med. 2020;7:590805. doi: 10.3389/fmed.2020.590805.
    1. Munshi R, Hussein MH, Toraih EA, et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol. 2021;93:733–740. doi: 10.1002/jmv.26360.
    1. Mariani J, Giménez VMM, Bergam I, et al. Association between vitamin D deficiency and COVID-19 incidence, complications, and mortality in 46 countries: an ecological study. Health Secur. 2020 doi: 10.1089/hs.2020.0137.
    1. Radujkovic A, Hippchen T, Tiwari-Heckler S, et al. Vitamin D deficiency and outcome of COVID-19 patients. Nutrients. 2020 doi: 10.3390/nu12092757.
    1. Baktash V, Hosack T, Patel N, et al. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J. 2020 doi: 10.1136/postgradmedj-2020-138712.
    1. Annweiler G, Corvaisier M, Gautier J, et al. Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study. Nutrients. 2020;12:3377. doi: 10.3390/nu12113377.
    1. Annweiler C, Hanotte B, Grandin de l’Eprevier C, et al. Vitamin D and survival in COVID-19 patients: a quasi-experimental study. J Steroid Biochem Mol Biol. 2020;204:105771. doi: 10.1016/j.jsbmb.2020.105771.
    1. Ling SF, Broad E, Murphy R, et al. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients. 2020;12:3799. doi: 10.3390/nu12123799.
    1. Giannini S, Passeri G, Tripepi G, et al. Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study. Nutrients. 2021;13:219. doi: 10.3390/nu13010219.
    1. Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study. J Steroid Biochem Mol Biol. 2020;203:105751. doi: 10.1016/j.jsbmb.2020.105751.
    1. Hernández JL, Nan D, Fernandez-Ayala M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab. 2020 doi: 10.1210/clinem/dgaa733.
    1. Jevalikar G, Mithal A, Singh A, et al. Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19. Sci Rep. 2021;11:6258. doi: 10.1038/s41598-021-85809-y.
    1. Cereda E, Bogliolo L, Lobascio F, et al. Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy. Italy Nutrition. 2021;82:111055. doi: 10.1016/j.nut.2020.111055.
    1. Murai IH, Fernandes AL, Sales LP, et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA. 2021;325:1053. doi: 10.1001/jama.2020.26848.
    1. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700–b2700. doi: 10.1136/bmj.b2700.
    1. Pal R, Bhadada SK (2021) Vitamin D supplementation and adverse clinical outcomes in COVID-19: a systematic review and meta-analysis. PROSPERO 2021 CRD42021248488.
    1. Wells G, Shea B, O’Connell D et al (2013) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
    1. Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Anal. 2017;5:80. doi: 10.13105/wjma.v5.i4.80.
    1. Higgins J, Sterne J, Savovic J, et al. A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev. 2016;10:29–31.
    1. Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560. doi: 10.1136/bmj.327.7414.557.
    1. Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, et al. Calcifediol treatment and hospital mortality due to COVID-19: a cohort study. Nutrients. 2021;13:1760. doi: 10.3390/nu13061760.
    1. Lohia P, Nguyen P, Patel N, Kapur S. Exploring the link between vitamin D and clinical outcomes in COVID-19. Am J Physiol-Endocrinol Metab. 2021;320:E520–E526. doi: 10.1152/ajpendo.00517.2020.
    1. Cangiano B, Fatti LM, Danesi L, et al. Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests. Aging. 2020;12:24522–24534. doi: 10.18632/aging.202307.
    1. Lakkireddy M, Gadiga SG, Malathi RD, et al. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep. 2021;11:10641. doi: 10.1038/s41598-021-90189-4.
    1. Rastogi A, Bhansali A, Khare N, et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) Postgrad Med J postgrad. 2020 doi: 10.1136/postgradmedj-2020-139065.
    1. Sánchez-Zuno GA, González-Estevez G, Matuz-Flores MG, et al. Vitamin D levels in COVID-19 outpatients from Western Mexico: clinical correlation and effect of its supplementation. J Clin Med. 2021;10:2378. doi: 10.3390/jcm10112378.
    1. Tan CW, Ho LP, Kalimuddin S, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) Nutrition. 2020;79–80:111017. doi: 10.1016/j.nut.2020.111017.
    1. Hernández JL, Nan D, Fernandez-Ayala M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. J Clin Endocrinol Metab. 2021;106:e1343–e1353. doi: 10.1210/clinem/dgaa733.
    1. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72:48–54. doi: 10.1111/nure.12090.
    1. Kaufman HW, Niles JK, Kroll MH, et al. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS ONE. 2020;15:e0239252. doi: 10.1371/journal.pone.0239252.
    1. Shah Alam M, Czajkowsky DM, Aminul Islam Md, Ataur Rahman Md. The role of vitamin D in reducing SARS-CoV-2 infection: an update. Int Immunopharmacol. 2021;97:107686. doi: 10.1016/j.intimp.2021.107686.
    1. Charoenngam N, Shirvani A, Reddy N, et al. Association of vitamin D status with hospital morbidity and mortality in adult hospitalized patients with COVID-19. Endocr Pract. 2021;27:271–278. doi: 10.1016/j.eprac.2021.02.013.
    1. Akbar MR, Wibowo A, Pranata R, Setiabudiawan B. Low Serum 25-hydroxyvitamin D (Vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Front Nutr. 2021;8:660420. doi: 10.3389/fnut.2021.660420.
    1. Teshome A, Adane A, Girma B, Mekonnen ZA. The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis. Front Public Health. 2021;9:624559. doi: 10.3389/fpubh.2021.624559.
    1. Pereira M, Dantas Damascena A, Galvão Azevedo LM, et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020 doi: 10.1080/10408398.2020.1841090.
    1. Bassatne A, Basbous M, Chakhtoura M, et al. The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism. 2021 doi: 10.1016/j.metabol.2021.154753.
    1. Mercola J, Grant WB, Wagner CL. Evidence regarding vitamin D and Risk of COVID-19 and its severity. Nutrients. 2020;12:3361. doi: 10.3390/nu12113361.
    1. Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D Supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988.
    1. Grant WB, Lahore H, Rockwell MS. The benefits of vitamin D supplementation for athletes: better performance and reduced risk of COVID-19. Nutrients. 2020;12:3741. doi: 10.3390/nu12123741.
    1. Brice DC, Diamond G. Antiviral activities of human host defense peptides. Curr Med Chem. 2020;27:1420–1443. doi: 10.2174/0929867326666190805151654.
    1. Raucci F, Mansour AA, Casillo GM, et al. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms. Autoimmun Rev. 2020;19:102572. doi: 10.1016/j.autrev.2020.102572.
    1. Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20:345–346. doi: 10.1038/s41577-020-0328-z.
    1. Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol. 2020;183:R133–R147. doi: 10.1530/EJE-20-0665.
    1. Zou Z, Yan Y, Shu Y, et al. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun. 2014 doi: 10.1038/ncomms4594.
    1. Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract. 2020;162:108132. doi: 10.1016/j.diabres.2020.108132.
    1. Malek Mahdavi A. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19. Rev Med Virol. 2020 doi: 10.1002/rmv.2119.
    1. Shah K, Saxena D, Mavalankar D. Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis. QJM Int J Med. 2021 doi: 10.1093/qjmed/hcab009.
    1. Annweiler C, Mercat A, Souberbielle J-C. Learning from previous methodological pitfalls to propose well-designed trials on vitamin D in COVID-19. J Steroid Biochem Mol Biol. 2021;211:105901. doi: 10.1016/j.jsbmb.2021.105901.
    1. Maghbooli Z, Sahraian MA, Ebrahimi M, et al. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS ONE. 2020;15:e0239799. doi: 10.1371/journal.pone.0239799.
    1. Kearns MD, Binongo JNG, Watson D, et al. The effect of a single, large bolus of vitamin D in healthy adults over the winter and following year: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2015;69:193–197. doi: 10.1038/ejcn.2014.209.
    1. Barker T, May HT, Doty JR, et al. Vitamin D supplementation protects against reductions in plasma 25-hydroxyvitamin D induced by open-heart surgery: Assess-d trial. Physiol Rep. 2021 doi: 10.14814/phy2.14747.
    1. Griffin G, Hewison M, Hopkin J, et al. Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19. Clin Med. 2021;21:e144–e149. doi: 10.7861/clinmed.2021-0035.
    1. Ketha H, Thacher TD, Oberhelman SS, et al. Comparison of the effect of daily versus bolus dose maternal vitamin D3 supplementation on the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio. Bone. 2018;110:321–325. doi: 10.1016/j.bone.2018.02.024.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi